4 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Fragment-Based Screening Identifies New Quinazolinone-Based Inositol Hexakisphosphate Kinase (IP6K) Inhibitors.
Lieber Institute For Brain Development
Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions.
University of North Carolina At Chapel Hill
Synthesis and characterization of novel isoform-selective IP6K1 inhibitors.
Johns Hopkins University School of Medicine